Physician profile
Gary Pitts
NPI 1467428318
$1,748.93
in general payments reported to CMS, 2019-2025
23 companies · $36.29 in 2025
The $36.29 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $127 · 2022: $112 · 2023: $546 · 2025: $36.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $405.77 | 2019-2023 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $241.41 | 2019-2023 | Arexvy, Shingrix |
| Abbvie INC. | $128.33 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $127.00 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $98.52 | 2019 | |
| Abbott Laboratories | $92.18 | 2022-2023 | Freestyle Libre 3 |
| Astellas Pharma US INC | $78.54 | 2019-2023 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $66.20 | 2019-2025 | Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $61.55 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.83 | 2019 | |
| Lilly USA, LLC | $56.31 | 2019-2023 | Mounjaro |
| Pfizer INC. | $54.51 | 2019-2020 | |
| Genentech USA, INC. | $48.42 | 2019-2020 | |
| Amgen INC. | $47.41 | 2019 | |
| Sobi, INC | $40.68 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $33.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.06 | 2019 | |
| Exact Sciences Corporation | $18.35 | 2025 | Cologuard Collection Kit |
| Acadia Pharmaceuticals INC | $14.11 | 2019 | |
| Tris Pharma INC | $13.61 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.78 | 2019 | |
| Amarin Pharma, INC. | $11.94 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.